Skip to content
Disclosery

EXANE DERIVATIVES: NEOG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NEOG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 10 NEOG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 10 shares
    Change vs previous 13F -2,831 shares

    <0.01% of the 13F portfolio, value $241.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,841 shares
    Change vs previous 13F -575 shares

    0.02% of the 13F portfolio, value $87,611.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,416 shares
    Change vs previous 13F -1,026 shares

    0.04% of the 13F portfolio, value $155,115.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,442 shares
    Change vs previous 13F -733 shares

    0.05% of the 13F portfolio, value $192,909.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,175 shares
    Change vs previous 13F +1,738 shares

    0.05% of the 13F portfolio, value $233,956.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,437 shares
    Change vs previous 13F -1,442 shares

    0.09% of the 13F portfolio, value $305,501.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,879 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $386,887.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).